nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.146	0.248	CbGbCtD
Desvenlafaxine—CYP3A4—Triamcinolone—psoriatic arthritis	0.11	0.188	CbGbCtD
Desvenlafaxine—CYP3A4—Betamethasone—psoriatic arthritis	0.0947	0.161	CbGbCtD
Desvenlafaxine—CYP3A4—Prednisolone—psoriatic arthritis	0.0934	0.159	CbGbCtD
Desvenlafaxine—CYP3A4—Prednisone—psoriatic arthritis	0.0882	0.15	CbGbCtD
Desvenlafaxine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0551	0.0938	CbGbCtD
Desvenlafaxine—Constipation—Auranofin—psoriatic arthritis	0.00338	0.00819	CcSEcCtD
Desvenlafaxine—Interstitial lung disease—Methotrexate—psoriatic arthritis	0.00303	0.00734	CcSEcCtD
Desvenlafaxine—Diarrhoea—Auranofin—psoriatic arthritis	0.0027	0.00655	CcSEcCtD
Desvenlafaxine—Vomiting—Auranofin—psoriatic arthritis	0.00251	0.00609	CcSEcCtD
Desvenlafaxine—Rash—Auranofin—psoriatic arthritis	0.00249	0.00604	CcSEcCtD
Desvenlafaxine—Dermatitis—Auranofin—psoriatic arthritis	0.00249	0.00603	CcSEcCtD
Desvenlafaxine—Proteinuria—Methotrexate—psoriatic arthritis	0.00244	0.00591	CcSEcCtD
Desvenlafaxine—Protein urine present—Methotrexate—psoriatic arthritis	0.00241	0.00583	CcSEcCtD
Desvenlafaxine—Musculoskeletal stiffness—Methotrexate—psoriatic arthritis	0.00239	0.00579	CcSEcCtD
Desvenlafaxine—Bone disorder—Methotrexate—psoriatic arthritis	0.00237	0.00575	CcSEcCtD
Desvenlafaxine—Nausea—Auranofin—psoriatic arthritis	0.00235	0.00569	CcSEcCtD
Desvenlafaxine—Irritability—Methylprednisolone—psoriatic arthritis	0.00224	0.00544	CcSEcCtD
Desvenlafaxine—Breast disorder—Methylprednisolone—psoriatic arthritis	0.00213	0.00515	CcSEcCtD
Desvenlafaxine—Irritability—Betamethasone—psoriatic arthritis	0.00204	0.00495	CcSEcCtD
Desvenlafaxine—Irritability—Dexamethasone—psoriatic arthritis	0.00204	0.00495	CcSEcCtD
Desvenlafaxine—Weight increased—Prednisolone—psoriatic arthritis	0.00202	0.00489	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00195	0.00472	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00194	0.00469	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.00186	0.00451	CcSEcCtD
Desvenlafaxine—Weight increased—Triamcinolone—psoriatic arthritis	0.00185	0.00449	CcSEcCtD
Desvenlafaxine—Weight increased—Methylprednisolone—psoriatic arthritis	0.00185	0.00448	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.00179	0.00434	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.00179	0.00433	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00178	0.00432	CcSEcCtD
Desvenlafaxine—Irritability—Prednisone—psoriatic arthritis	0.00178	0.00431	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00178	0.00431	CcSEcCtD
Desvenlafaxine—Epistaxis—Triamcinolone—psoriatic arthritis	0.00171	0.00415	CcSEcCtD
Desvenlafaxine—Weight increased—Betamethasone—psoriatic arthritis	0.00168	0.00408	CcSEcCtD
Desvenlafaxine—Weight increased—Dexamethasone—psoriatic arthritis	0.00168	0.00408	CcSEcCtD
Desvenlafaxine—Weight decreased—Betamethasone—psoriatic arthritis	0.00167	0.00405	CcSEcCtD
Desvenlafaxine—Weight decreased—Dexamethasone—psoriatic arthritis	0.00167	0.00405	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00162	0.00394	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00162	0.00394	CcSEcCtD
Desvenlafaxine—Hallucination—Methylprednisolone—psoriatic arthritis	0.00162	0.00392	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00162	0.00392	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00162	0.00392	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.0016	0.00387	CcSEcCtD
Desvenlafaxine—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00152	0.00369	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00151	0.00366	CcSEcCtD
Desvenlafaxine—Irritability—Methotrexate—psoriatic arthritis	0.00149	0.0036	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00148	0.00359	CcSEcCtD
Desvenlafaxine—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00148	0.00358	CcSEcCtD
Desvenlafaxine—Hallucination—Betamethasone—psoriatic arthritis	0.00147	0.00357	CcSEcCtD
Desvenlafaxine—Hallucination—Dexamethasone—psoriatic arthritis	0.00147	0.00357	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00147	0.00356	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00147	0.00355	CcSEcCtD
Desvenlafaxine—Weight increased—Prednisone—psoriatic arthritis	0.00147	0.00355	CcSEcCtD
Desvenlafaxine—Weight decreased—Prednisone—psoriatic arthritis	0.00146	0.00353	CcSEcCtD
Desvenlafaxine—Vision blurred—Prednisolone—psoriatic arthritis	0.00145	0.00353	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.00144	0.00348	CcSEcCtD
Desvenlafaxine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00143	0.00345	CcSEcCtD
Desvenlafaxine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00142	0.00343	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00141	0.00343	CcSEcCtD
Desvenlafaxine—Angioedema—Prednisolone—psoriatic arthritis	0.00141	0.00342	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Prednisone—psoriatic arthritis	0.00141	0.00341	CcSEcCtD
Desvenlafaxine—Breast disorder—Methotrexate—psoriatic arthritis	0.00141	0.00341	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.0014	0.0034	CcSEcCtD
Desvenlafaxine—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00139	0.00337	CcSEcCtD
Desvenlafaxine—Vertigo—Prednisolone—psoriatic arthritis	0.00139	0.00336	CcSEcCtD
Desvenlafaxine—Syncope—Prednisolone—psoriatic arthritis	0.00138	0.00335	CcSEcCtD
Desvenlafaxine—Eye disorder—Dexamethasone—psoriatic arthritis	0.00138	0.00335	CcSEcCtD
Desvenlafaxine—Eye disorder—Betamethasone—psoriatic arthritis	0.00138	0.00335	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00136	0.00329	CcSEcCtD
Desvenlafaxine—Angiopathy—Dexamethasone—psoriatic arthritis	0.00134	0.00325	CcSEcCtD
Desvenlafaxine—Angiopathy—Betamethasone—psoriatic arthritis	0.00134	0.00325	CcSEcCtD
Desvenlafaxine—Convulsion—Prednisolone—psoriatic arthritis	0.00134	0.00324	CcSEcCtD
Desvenlafaxine—Hypertension—Prednisolone—psoriatic arthritis	0.00133	0.00323	CcSEcCtD
Desvenlafaxine—Alopecia—Dexamethasone—psoriatic arthritis	0.00131	0.00317	CcSEcCtD
Desvenlafaxine—Alopecia—Betamethasone—psoriatic arthritis	0.00131	0.00317	CcSEcCtD
Desvenlafaxine—Angioedema—Triamcinolone—psoriatic arthritis	0.0013	0.00314	CcSEcCtD
Desvenlafaxine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00129	0.00314	CcSEcCtD
Desvenlafaxine—Hallucination—Prednisone—psoriatic arthritis	0.00128	0.00311	CcSEcCtD
Desvenlafaxine—Vertigo—Triamcinolone—psoriatic arthritis	0.00128	0.00309	CcSEcCtD
Desvenlafaxine—Syncope—Triamcinolone—psoriatic arthritis	0.00127	0.00309	CcSEcCtD
Desvenlafaxine—Vertigo—Methylprednisolone—psoriatic arthritis	0.00127	0.00308	CcSEcCtD
Desvenlafaxine—Syncope—Methylprednisolone—psoriatic arthritis	0.00127	0.00308	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00127	0.00307	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00125	0.00302	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00124	0.00302	CcSEcCtD
Desvenlafaxine—Shock—Prednisolone—psoriatic arthritis	0.00124	0.003	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00124	0.003	CcSEcCtD
Desvenlafaxine—Convulsion—Triamcinolone—psoriatic arthritis	0.00123	0.00298	CcSEcCtD
Desvenlafaxine—Tachycardia—Prednisolone—psoriatic arthritis	0.00123	0.00298	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00123	0.00298	CcSEcCtD
Desvenlafaxine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00123	0.00297	CcSEcCtD
Desvenlafaxine—Hypertension—Triamcinolone—psoriatic arthritis	0.00123	0.00297	CcSEcCtD
Desvenlafaxine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00122	0.00296	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00122	0.00295	CcSEcCtD
Desvenlafaxine—Eye disorder—Prednisone—psoriatic arthritis	0.0012	0.00292	CcSEcCtD
Desvenlafaxine—Anxiety—Methylprednisolone—psoriatic arthritis	0.0012	0.00291	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.0012	0.0029	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00119	0.00288	CcSEcCtD
Desvenlafaxine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00118	0.00286	CcSEcCtD
Desvenlafaxine—Angioedema—Dexamethasone—psoriatic arthritis	0.00118	0.00285	CcSEcCtD
Desvenlafaxine—Angioedema—Betamethasone—psoriatic arthritis	0.00118	0.00285	CcSEcCtD
Desvenlafaxine—Angiopathy—Prednisone—psoriatic arthritis	0.00117	0.00283	CcSEcCtD
Desvenlafaxine—Immune system disorder—Prednisone—psoriatic arthritis	0.00116	0.00282	CcSEcCtD
Desvenlafaxine—Vertigo—Dexamethasone—psoriatic arthritis	0.00116	0.0028	CcSEcCtD
Desvenlafaxine—Vertigo—Betamethasone—psoriatic arthritis	0.00116	0.0028	CcSEcCtD
Desvenlafaxine—Syncope—Betamethasone—psoriatic arthritis	0.00116	0.0028	CcSEcCtD
Desvenlafaxine—Syncope—Dexamethasone—psoriatic arthritis	0.00116	0.0028	CcSEcCtD
Desvenlafaxine—Shock—Triamcinolone—psoriatic arthritis	0.00114	0.00276	CcSEcCtD
Desvenlafaxine—Insomnia—Prednisolone—psoriatic arthritis	0.00114	0.00276	CcSEcCtD
Desvenlafaxine—Alopecia—Prednisone—psoriatic arthritis	0.00114	0.00276	CcSEcCtD
Desvenlafaxine—Shock—Methylprednisolone—psoriatic arthritis	0.00114	0.00276	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00113	0.00275	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00113	0.00274	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00113	0.00274	CcSEcCtD
Desvenlafaxine—Epistaxis—Methotrexate—psoriatic arthritis	0.00113	0.00274	CcSEcCtD
Desvenlafaxine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00113	0.00274	CcSEcCtD
Desvenlafaxine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00113	0.00274	CcSEcCtD
Desvenlafaxine—Mental disorder—Prednisone—psoriatic arthritis	0.00113	0.00274	CcSEcCtD
Desvenlafaxine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00113	0.00273	CcSEcCtD
Desvenlafaxine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00112	0.00272	CcSEcCtD
Desvenlafaxine—Malnutrition—Prednisone—psoriatic arthritis	0.00112	0.00272	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00112	0.00271	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00112	0.00271	CcSEcCtD
Desvenlafaxine—Convulsion—Dexamethasone—psoriatic arthritis	0.00112	0.0027	CcSEcCtD
Desvenlafaxine—Convulsion—Betamethasone—psoriatic arthritis	0.00112	0.0027	CcSEcCtD
Desvenlafaxine—Hypertension—Dexamethasone—psoriatic arthritis	0.00111	0.0027	CcSEcCtD
Desvenlafaxine—Hypertension—Betamethasone—psoriatic arthritis	0.00111	0.0027	CcSEcCtD
Desvenlafaxine—Anxiety—Dexamethasone—psoriatic arthritis	0.00109	0.00265	CcSEcCtD
Desvenlafaxine—Anxiety—Betamethasone—psoriatic arthritis	0.00109	0.00265	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00106	0.00258	CcSEcCtD
Desvenlafaxine—Vision blurred—Prednisone—psoriatic arthritis	0.00106	0.00256	CcSEcCtD
Desvenlafaxine—Urethral disorder—Methotrexate—psoriatic arthritis	0.00106	0.00256	CcSEcCtD
Desvenlafaxine—Insomnia—Triamcinolone—psoriatic arthritis	0.00105	0.00254	CcSEcCtD
Desvenlafaxine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00105	0.00253	CcSEcCtD
Desvenlafaxine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00104	0.00252	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00104	0.00252	CcSEcCtD
Desvenlafaxine—Shock—Betamethasone—psoriatic arthritis	0.00103	0.00251	CcSEcCtD
Desvenlafaxine—Shock—Dexamethasone—psoriatic arthritis	0.00103	0.00251	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00103	0.0025	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00103	0.0025	CcSEcCtD
Desvenlafaxine—Tachycardia—Betamethasone—psoriatic arthritis	0.00103	0.00249	CcSEcCtD
Desvenlafaxine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00103	0.00249	CcSEcCtD
Desvenlafaxine—Angioedema—Prednisone—psoriatic arthritis	0.00102	0.00248	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00102	0.00247	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00102	0.00246	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00102	0.00246	CcSEcCtD
Desvenlafaxine—Vertigo—Prednisone—psoriatic arthritis	0.00101	0.00244	CcSEcCtD
Desvenlafaxine—Eye disorder—Methotrexate—psoriatic arthritis	0.00101	0.00244	CcSEcCtD
Desvenlafaxine—Syncope—Prednisone—psoriatic arthritis	0.00101	0.00244	CcSEcCtD
Desvenlafaxine—Tinnitus—Methotrexate—psoriatic arthritis	0.001	0.00243	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000999	0.00242	CcSEcCtD
Desvenlafaxine—Fatigue—Triamcinolone—psoriatic arthritis	0.000999	0.00242	CcSEcCtD
Desvenlafaxine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000997	0.00242	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000986	0.00239	CcSEcCtD
Desvenlafaxine—Angiopathy—Methotrexate—psoriatic arthritis	0.000977	0.00237	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000973	0.00236	CcSEcCtD
Desvenlafaxine—Convulsion—Prednisone—psoriatic arthritis	0.000972	0.00236	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000971	0.00235	CcSEcCtD
Desvenlafaxine—Hypertension—Prednisone—psoriatic arthritis	0.000968	0.00235	CcSEcCtD
Desvenlafaxine—Chills—Methotrexate—psoriatic arthritis	0.000966	0.00234	CcSEcCtD
Desvenlafaxine—Anxiety—Prednisone—psoriatic arthritis	0.000952	0.00231	CcSEcCtD
Desvenlafaxine—Alopecia—Methotrexate—psoriatic arthritis	0.000952	0.00231	CcSEcCtD
Desvenlafaxine—Insomnia—Betamethasone—psoriatic arthritis	0.000951	0.0023	CcSEcCtD
Desvenlafaxine—Insomnia—Dexamethasone—psoriatic arthritis	0.000951	0.0023	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000948	0.0023	CcSEcCtD
Desvenlafaxine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000944	0.00229	CcSEcCtD
Desvenlafaxine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000944	0.00229	CcSEcCtD
Desvenlafaxine—Mental disorder—Methotrexate—psoriatic arthritis	0.000943	0.00229	CcSEcCtD
Desvenlafaxine—Malnutrition—Methotrexate—psoriatic arthritis	0.000937	0.00227	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000928	0.00225	CcSEcCtD
Desvenlafaxine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000918	0.00222	CcSEcCtD
Desvenlafaxine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000914	0.00221	CcSEcCtD
Desvenlafaxine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000914	0.00221	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000908	0.0022	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000908	0.0022	CcSEcCtD
Desvenlafaxine—Fatigue—Dexamethasone—psoriatic arthritis	0.000906	0.0022	CcSEcCtD
Desvenlafaxine—Fatigue—Betamethasone—psoriatic arthritis	0.000906	0.0022	CcSEcCtD
Desvenlafaxine—Shock—Prednisone—psoriatic arthritis	0.000901	0.00218	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000898	0.00218	CcSEcCtD
Desvenlafaxine—Tachycardia—Prednisone—psoriatic arthritis	0.000893	0.00217	CcSEcCtD
Desvenlafaxine—Skin disorder—Prednisone—psoriatic arthritis	0.000889	0.00215	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000885	0.00214	CcSEcCtD
Desvenlafaxine—Vision blurred—Methotrexate—psoriatic arthritis	0.000883	0.00214	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000854	0.00207	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000852	0.00206	CcSEcCtD
Desvenlafaxine—Vertigo—Methotrexate—psoriatic arthritis	0.000842	0.00204	CcSEcCtD
Desvenlafaxine—Dizziness—Prednisolone—psoriatic arthritis	0.000833	0.00202	CcSEcCtD
Desvenlafaxine—Asthenia—Triamcinolone—psoriatic arthritis	0.000831	0.00201	CcSEcCtD
Desvenlafaxine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000829	0.00201	CcSEcCtD
Desvenlafaxine—Insomnia—Prednisone—psoriatic arthritis	0.000828	0.00201	CcSEcCtD
Desvenlafaxine—Paraesthesia—Prednisone—psoriatic arthritis	0.000822	0.00199	CcSEcCtD
Desvenlafaxine—Convulsion—Methotrexate—psoriatic arthritis	0.000812	0.00197	CcSEcCtD
Desvenlafaxine—Decreased appetite—Prednisone—psoriatic arthritis	0.000796	0.00193	CcSEcCtD
Desvenlafaxine—Rash—Prednisolone—psoriatic arthritis	0.000794	0.00193	CcSEcCtD
Desvenlafaxine—Dermatitis—Prednisolone—psoriatic arthritis	0.000794	0.00192	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000793	0.00192	CcSEcCtD
Desvenlafaxine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000791	0.00192	CcSEcCtD
Desvenlafaxine—Fatigue—Prednisone—psoriatic arthritis	0.000789	0.00191	CcSEcCtD
Desvenlafaxine—Headache—Prednisolone—psoriatic arthritis	0.000789	0.00191	CcSEcCtD
Desvenlafaxine—Constipation—Prednisone—psoriatic arthritis	0.000783	0.0019	CcSEcCtD
Desvenlafaxine—Dizziness—Triamcinolone—psoriatic arthritis	0.000766	0.00186	CcSEcCtD
Desvenlafaxine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000764	0.00185	CcSEcCtD
Desvenlafaxine—Asthenia—Dexamethasone—psoriatic arthritis	0.000754	0.00183	CcSEcCtD
Desvenlafaxine—Asthenia—Betamethasone—psoriatic arthritis	0.000754	0.00183	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00075	0.00182	CcSEcCtD
Desvenlafaxine—Nausea—Prednisolone—psoriatic arthritis	0.000748	0.00181	CcSEcCtD
Desvenlafaxine—Skin disorder—Methotrexate—psoriatic arthritis	0.000743	0.0018	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00074	0.00179	CcSEcCtD
Desvenlafaxine—Vomiting—Triamcinolone—psoriatic arthritis	0.000737	0.00179	CcSEcCtD
Desvenlafaxine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000735	0.00178	CcSEcCtD
Desvenlafaxine—Rash—Triamcinolone—psoriatic arthritis	0.00073	0.00177	CcSEcCtD
Desvenlafaxine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00073	0.00177	CcSEcCtD
Desvenlafaxine—Rash—Methylprednisolone—psoriatic arthritis	0.000729	0.00177	CcSEcCtD
Desvenlafaxine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000728	0.00176	CcSEcCtD
Desvenlafaxine—Headache—Triamcinolone—psoriatic arthritis	0.000726	0.00176	CcSEcCtD
Desvenlafaxine—Headache—Methylprednisolone—psoriatic arthritis	0.000724	0.00176	CcSEcCtD
Desvenlafaxine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000719	0.00174	CcSEcCtD
Desvenlafaxine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000719	0.00174	CcSEcCtD
Desvenlafaxine—Dizziness—Betamethasone—psoriatic arthritis	0.000695	0.00168	CcSEcCtD
Desvenlafaxine—Dizziness—Dexamethasone—psoriatic arthritis	0.000695	0.00168	CcSEcCtD
Desvenlafaxine—Insomnia—Methotrexate—psoriatic arthritis	0.000692	0.00168	CcSEcCtD
Desvenlafaxine—Nausea—Triamcinolone—psoriatic arthritis	0.000688	0.00167	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000687	0.00166	CcSEcCtD
Desvenlafaxine—Nausea—Methylprednisolone—psoriatic arthritis	0.000687	0.00166	CcSEcCtD
Desvenlafaxine—Somnolence—Methotrexate—psoriatic arthritis	0.00068	0.00165	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000674	0.00163	CcSEcCtD
Desvenlafaxine—Vomiting—Dexamethasone—psoriatic arthritis	0.000668	0.00162	CcSEcCtD
Desvenlafaxine—Vomiting—Betamethasone—psoriatic arthritis	0.000668	0.00162	CcSEcCtD
Desvenlafaxine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000665	0.00161	CcSEcCtD
Desvenlafaxine—Rash—Betamethasone—psoriatic arthritis	0.000663	0.00161	CcSEcCtD
Desvenlafaxine—Rash—Dexamethasone—psoriatic arthritis	0.000663	0.00161	CcSEcCtD
Desvenlafaxine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000662	0.0016	CcSEcCtD
Desvenlafaxine—Dermatitis—Betamethasone—psoriatic arthritis	0.000662	0.0016	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000661	0.0016	CcSEcCtD
Desvenlafaxine—Fatigue—Methotrexate—psoriatic arthritis	0.00066	0.0016	CcSEcCtD
Desvenlafaxine—Headache—Dexamethasone—psoriatic arthritis	0.000659	0.0016	CcSEcCtD
Desvenlafaxine—Headache—Betamethasone—psoriatic arthritis	0.000659	0.0016	CcSEcCtD
Desvenlafaxine—Asthenia—Prednisone—psoriatic arthritis	0.000657	0.00159	CcSEcCtD
Desvenlafaxine—Diarrhoea—Prednisone—psoriatic arthritis	0.000626	0.00152	CcSEcCtD
Desvenlafaxine—Nausea—Dexamethasone—psoriatic arthritis	0.000624	0.00151	CcSEcCtD
Desvenlafaxine—Nausea—Betamethasone—psoriatic arthritis	0.000624	0.00151	CcSEcCtD
Desvenlafaxine—Dizziness—Prednisone—psoriatic arthritis	0.000605	0.00147	CcSEcCtD
Desvenlafaxine—Vomiting—Prednisone—psoriatic arthritis	0.000582	0.00141	CcSEcCtD
Desvenlafaxine—Rash—Prednisone—psoriatic arthritis	0.000577	0.0014	CcSEcCtD
Desvenlafaxine—Dermatitis—Prednisone—psoriatic arthritis	0.000577	0.0014	CcSEcCtD
Desvenlafaxine—Headache—Prednisone—psoriatic arthritis	0.000573	0.00139	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000564	0.00137	CcSEcCtD
Desvenlafaxine—Asthenia—Methotrexate—psoriatic arthritis	0.000549	0.00133	CcSEcCtD
Desvenlafaxine—Nausea—Prednisone—psoriatic arthritis	0.000544	0.00132	CcSEcCtD
Desvenlafaxine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000523	0.00127	CcSEcCtD
Desvenlafaxine—Dizziness—Methotrexate—psoriatic arthritis	0.000506	0.00123	CcSEcCtD
Desvenlafaxine—Vomiting—Methotrexate—psoriatic arthritis	0.000486	0.00118	CcSEcCtD
Desvenlafaxine—Rash—Methotrexate—psoriatic arthritis	0.000482	0.00117	CcSEcCtD
Desvenlafaxine—Dermatitis—Methotrexate—psoriatic arthritis	0.000482	0.00117	CcSEcCtD
Desvenlafaxine—Headache—Methotrexate—psoriatic arthritis	0.000479	0.00116	CcSEcCtD
Desvenlafaxine—Nausea—Methotrexate—psoriatic arthritis	0.000454	0.0011	CcSEcCtD
